Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4889 USD | -3.26% | +0.10% | -61.20% |
Mar. 11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
Mar. 04 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 26.84M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.48
x | P/E ratio 2025 * |
-
| Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.72% |
1 day | -3.26% | ||
1 week | +0.10% | ||
Current month | -7.51% | ||
1 month | -13.62% | ||
3 months | -48.13% | ||
6 months | -84.48% | ||
Current year | -61.20% |
Managers | Title | Age | Since |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 16-04-10 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 18-09-30 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 20-06-15 |
Richard Berman
BRD | Director/Board Member | 81 | 19-06-23 |
Jim Lang
CHM | Chairman | 59 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.4889 | -3.26% | 785,274 |
24-04-24 | 0.5054 | +2.77% | 878,438 |
24-04-23 | 0.4918 | +1.78% | 704,400 |
24-04-22 | 0.4832 | -0.68% | 451,590 |
24-04-19 | 0.4865 | -0.39% | 531,966 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.20% | 26.84M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.70% | 22.02B | |
-17.84% | 20.9B | |
-9.33% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- BIVI Stock